Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 7

B.

Pharm 4th year


Semester VII
MC II
November 2014

Antibacterial agents
Chloramphenicol

Chloramphenicol

MOA
Inhibits protein synthesis ( 50 s subunit )
Bacteriostatic, bactericidal for some species
Blacks elongation of proteins by inhibiting
formation of initiation complexes and
peptidyltransferase

Pharmacokinetics

Rapidly & completely absorbed from GIT


30 % protein bound
Metabolized by liver glucuronidation
Well distributed, including CNS and CSF
Excreted in urine

Spectrum of action

Antibacterial activity
H. Influenzae
N. Meningitidis
S. Pneumoniae
Ricketsiae
& B. fragilis

S. typhi
E. coli
V.cholera
Anaerobes- clostridium

Clinical uses

Limited because of potential toxicities


Anaemia & circulatory collapse in neonates
Typhoid fever- s. typhi (Quinolones are preffered)
Meningitis H. influenzae, N. meningitidis, S.
pneumoniae (Ceftriaxone is preffered )
Anaerobic infections- B. fragilis (Metronidazole is the
drug of choice)
Rickettsial infections Doxycycline is preffered
Bacterial conjunctivitis (topical )

Side effects

Hypersensitivity- low incidence


May ppt hemolysis in G6PD deficient pts
Anaemia (fatal )
Grey baby syndrome
Suprainfections
Interaction with other drugs :
Inhibits liver microsomal enzymes

Phenytoin
Tolbutamide
Chlorpropamide
Anticoagulants

You might also like